Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group
Conferences > CLEO_SI > 2019 > SM4H > SM4H.4

Determining Metabolic Changes Associated with Tamoxifen Treatment and Resistance in Breast Cancer

David Rodriguez, Yan Zheng, Kevin D. Houston, and Jessica P. Houston

Not Accessible

Your library or personal account may give you access

Abstract

Autofluorescence lifetimes of endogenous NAD(P)H are altered when breast cancer cells are treated with tamoxifen and is distinguishable when comparing tamoxifen sensitive and resistant breast cancer cells.

© 2019 The Author(s)

PDF Article
More Like This
Spectral Flow Cytometry to Distinguish Tamoxifen Resistant Breast Cancer Cells

Aric C. Bitton, Jessica P. Houston, and Kevin D. Houston
JW2A.6 CLEO: Applications and Technology (CLEO:A&T) 2020

Few-cycle laser for the in vitro study of cellular bioenergetics during therapeutic treatment with the anticancer drug Doxorubicin in its free and liposomal nanocarrier form

Rodrigo Ferreira, Christian Maibohm, Oscar F. Silvestre, Rosa Romero, Helder Crespo, and Jana B. Nieder
cl_1_5 The European Conference on Lasers and Electro-Optics (CLEO/Europe) 2019

Probing chemosensitivity and energy metabolism in patients-derived colorectal cancer cells

Irina Druzhkova, Maria Lukina, Nadezhda Ignatova, Varvara Dudenkova, Marina Shirmanova, Vladimir Zagainov, Nikolay Kiselev, Lyubov’ Shimolina, and Elena Zagaynova
11076_57 European Conference on Biomedical Optics (ECBO) 2019

View More...
Select as filters
Select Topics Cancel
Top
       
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
Privacy | Terms of Use